Zepbound leads to more weight loss than Wegovy, new study finds
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...
Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...
"But at $700 a month, that's not going to happen." Even as weight loss drugs such as Wegovy and Zepbound explode in ...
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
11hOpinion
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback